Moran Wealth Management LLC Has $1.30 Million Holdings in ARK Genomic Revolution ETF $ARKG

Moran Wealth Management LLC boosted its position in shares of ARK Genomic Revolution ETF (BATS:ARKG) by 79.6% in the first quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 49,204 shares of the company’s stock after purchasing an additional 21,811 shares during the period. Moran Wealth Management LLC’s holdings in ARK Genomic Revolution ETF were worth $1,300,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors have also recently modified their holdings of the company. Private Advisor Group LLC boosted its position in shares of ARK Genomic Revolution ETF by 2.9% during the first quarter. Private Advisor Group LLC now owns 21,144 shares of the company’s stock worth $559,000 after buying an additional 605 shares during the period. Summit Investment Advisory Services LLC grew its holdings in shares of ARK Genomic Revolution ETF by 5.6% during the first quarter. Summit Investment Advisory Services LLC now owns 9,270 shares of the company’s stock worth $245,000 after buying an additional 495 shares in the last quarter. Midwest Financial Partners Investments Inc. raised its position in ARK Genomic Revolution ETF by 2.1% in the 1st quarter. Midwest Financial Partners Investments Inc. now owns 209,416 shares of the company’s stock valued at $5,533,000 after buying an additional 4,230 shares during the last quarter. Hilton Head Capital Partners LLC raised its position in ARK Genomic Revolution ETF by 161.4% in the 1st quarter. Hilton Head Capital Partners LLC now owns 1,537 shares of the company’s stock valued at $41,000 after buying an additional 949 shares during the last quarter. Finally, Wealth Management Partners LLC bought a new stake in ARK Genomic Revolution ETF in the 1st quarter valued at approximately $226,000.

ARK Genomic Revolution ETF Trading Down 3.2%

BATS:ARKG traded down $1.40 during trading hours on Tuesday, reaching $42.17. 843,724 shares of the stock were exchanged, compared to its average volume of 2,994,927. ARK Genomic Revolution ETF has a twelve month low of $22.73 and a twelve month high of $44.47. The firm has a 50 day moving average of $33.84 and a 200 day moving average of $30.85.

ARK Genomic Revolution ETF Company Profile

The ARK Genomic Revolution ETF (ARKG) is an exchange-traded fund that mostly invests in stocks based on a particular theme. The fund is an actively managed fund that targets companies involved in the genomics industry. ARKG was launched on Oct 31, 2014 and is managed by ARK.